D. Dunning et al., ANALYSIS OF PROGNOSTIC INDICATORS FOR DOGS WITH PERICARDIAL-EFFUSION - 46 CASES (1985-1996), Journal of the American Veterinary Medical Association, 212(8), 1998, pp. 1276
Objective-To determine factors associated with disease-free interval a
nd survival time for dogs with pericardial effusion. Design-Retrospect
ive study. Animals-46 dogs. Procedure-Signalment, history, results of
physical examination, electrocardiography, echocardiography, and thora
cic radiography; disease-free interval; and survival lime were obtaine
d from medical records or telephone conversations with owners and refe
rring veterinarians. Results-Dogs that had ascites at the time of the
initial physical examination were significantly less likely, and dogs
that had evidence of pulmonary metastases on thoracic radiographs or t
hat had echocardiographic evidence of a right atrial mass were signifi
cantly more likely, to have died of pericardial effusion or the underl
ying cause of effusion than were dogs that did not. Median survival ti
me was 15.3 months for dogs with idiopathic pericardial effusion, 16 d
ays for dogs with hemangiosarcoma, and 13.6 months for dogs with mesot
helioma. Dogs that had a nonspecific extracardiac mass and underwent p
ericardiectomy were significantly less likely to have had recurrence o
f signs than were dogs that did not. However, dogs with mesothelioma o
r hemangiosarcoma that underwent pericardiectomy did not have a signif
icantly different risk of recurrence of signs or survival lime, compar
ed with dogs that did not. Clinical implications-Results suggest that
pericardiectomy will not affect risk of recurrence or survival lime in
dogs with pericardial effusion secondary to hemangiosarcoma or mesoth
elioma, However, pericardiectomy is still needed to differentiate dogs
with neoplastic pericardial effusion from dogs with idiopathic perica
rdial effusion.